Mitochondria determine response to anti-programmed cell death protein-1 (anti-PD-1) immunotherapy: An evidence-based

Hassan Akbari1, Farzad Taghizadeh-Hesary2, Moslem Bahadori3

  • 1Department of Pathology, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Traditional Medicine School, Tehran University of Medical Sciences, Tehran, Iran.

Mitochondrion
|December 10, 2021
PubMed

Insights

Cellular adenosine triphosphate (ATP) levels predict response to cancer immunotherapy. Low ATP impairs T cell function, highlighting mitochondria

Area of Science:

  • Oncology
  • Immunology
  • Cellular Biology

Background:

  • Programmed cell death protein-1 (PD-1) immunotherapy shows promise in cancer treatment.
  • A significant number of patients do not respond to PD-1 blockade therapy.
  • Identifying predictive factors for PD-1 blockade response is crucial.

Purpose of the Study:

  • To provide an overview of potential predictive factors for PD-1 blockade therapy.
  • To emphasize the role of mitochondria in anti-PD-1 therapy response.

Main Methods:

  • Literature review of predictive factors for PD-1 blockade.
  • Analysis of the role of cellular adenosine triphosphate (c-ATP) in T cell function.
  • Examination of mitochondrial involvement in immunotherapy response.

Main Results:

  • Decreased cellular adenosine triphosphate (c-ATP) levels are linked to cellular dysfunction.
  • ATP is essential for T cell migration and activation.
  • Reduced c-ATP impairs T cell function and may promote cancer progression.

Conclusions:

  • Cellular adenosine triphosphate (c-ATP) levels may serve as a predictive factor for PD-1 blockade efficacy.
  • Mitochondrial function is critical for effective anti-PD-1 therapy.
  • Further research into c-ATP and mitochondria could improve patient selection for immunotherapy.

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
4.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
723
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.0K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.7K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.3K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K